Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study.

Mariani G, Galli G, Cavalieri S, Valagussa P, Bianchi GV, Capri G, Cresta S, Ferrari L, Damian S, Duca M, de Braud F, Moliterni A.

Breast J. 2019 Mar;25(2):237-242. doi: 10.1111/tbj.13197. Epub 2019 Feb 27.


Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies.

Cona MS, Lecchi M, Cresta S, Damian S, Del Vecchio M, Necchi A, Poggi MM, Raggi D, Randon G, Ratta R, Signorelli D, Vernieri C, de Braud F, Verderio P, Di Nicola M.

Cancers (Basel). 2019 Feb 14;11(2). pii: E223. doi: 10.3390/cancers11020223.


A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer.

Schöffski P, Cresta S, Mayer IA, Wildiers H, Damian S, Gendreau S, Rooney I, Morrissey KM, Spoerke JM, Ng VW, Singel SM, Winer E.

Breast Cancer Res. 2018 Sep 5;20(1):109. doi: 10.1186/s13058-018-1015-x.


Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study.

Cohen RB, Delord JP, Doi T, Piha-Paul SA, Liu SV, Gilbert J, Algazi AP, Damian S, Hong RL, Le Tourneau C, Day D, Varga A, Elez E, Wallmark J, Saraf S, Thanigaimani P, Cheng J, Keam B.

Am J Clin Oncol. 2018 Feb 21. doi: 10.1097/COC.0000000000000429. [Epub ahead of print]


Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).

Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson AD, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG.

Cancer Discov. 2017 Apr;7(4):400-409. doi: 10.1158/2159-8290.CD-16-1237. Epub 2017 Feb 9.


The anxiolitic effects of BTG1640 and BTG1675A on ultrasonic isolation calls and locomotor activity of rat pups.

Niculescu M, Cagiano R, Caprio M, Damian S, Boia E, Vermesan D, Tattoli M, Haragus H.

Eur Rev Med Pharmacol Sci. 2016 Dec;20(23):4980-4984.


A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.

Azaro A, Rodón J, Machiels JP, Rottey S, Damian S, Baird R, Garcia-Corbacho J, Mathijssen RHJ, Clot PF, Wack C, Shen L, de Jonge MJA.

Cancer Chemother Pharmacol. 2016 Dec;78(6):1185-1197. doi: 10.1007/s00280-016-3175-7. Epub 2016 Oct 27.


Drain tip cultures do not predict infections in primary total knee arthroplasty.

Lazureanu V, Radu D, Vermesan D, Prejbeanu R, Florescu S, Trocan I, Damian S, Inchingolo F, Abbinante A, Dipalma G, Caprio M, Cagiano R, Potenza MA, Haragus H.

Clin Ter. 2015;166(3):e153-7. doi: 10.7417/CT.2015.1846.


From punishment to education--juvenile delinquency in Romanian criminal law.

Ioan B, Damian S, Scripcaru C, Neagu M, Chirilă B.

Rev Med Chir Soc Med Nat Iasi. 2015 Jan-Mar;119(1):207-13.


Utility of autopsy in medical education--students' opinions and attitudes.

Ioan B, Neagu M, Manoilescu I, Plăieşu T, Damian S.

Rev Med Chir Soc Med Nat Iasi. 2014 Jul-Sep;118(3):801-7.


Ethical evaluation model for technologies. the role of medical technology in the development of autonomy in diabetes patient.

Damian S, Necula R, Sandu A, Iliescu ML, Ioan B.

Rev Med Chir Soc Med Nat Iasi. 2013 Jul-Sep;117(3):722-30.


Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? Analysis of a phase II trial.

Damian S, Celio L, De Benedictis E, Mariani P, Agustoni F, Ricchini F, De Braud F.

Oncology. 2013;84(6):371-7. doi: 10.1159/000348538. Epub 2013 May 22.


Medical and ethical dilemma in brain death.

Streba I, Damian S, Ioan B.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):731-8.


[Epidemiological and forensic medical considerations regarding frequency and causes of violent deaths in Iaşi. County, between 1997-2006].

Vornicu D, Damian S, Azoicăi D, Matei MC, Manole A.

Rev Med Chir Soc Med Nat Iasi. 2011 Jan-Mar;115(1):195-9. Romanian.


[Epidemiologic and forensic medical assessment of suicide incidence and other causes of violent death in Romania and Iaşi, between 1997 and 2006].

Vornicu D, Damian S, Azoicăi D.

Rev Med Chir Soc Med Nat Iasi. 2010 Jul-Sep;114(3):711-4. Romanian.


[Investigation of statistic data evolution with social impact].

Damian SI, Mihai D, Damian RF.

Rev Med Chir Soc Med Nat Iasi. 2008 Jul-Sep;112(3):764-8. Romanian.


Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate.

Panasci L, Jean-Claude BJ, Vasilescu D, Mustafa A, Damian S, Damian Z, Georges E, Liu Z, Batist G, Leyland-Jones B.

Biochem Pharmacol. 1996 Oct 11;52(7):1097-102.


Supplemental Content

Loading ...
Support Center